Or Refractory Non-hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-03-21
Clinical Trial Update: First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL [Phase 1]
First-in-human, single-agent study of SAR442257 in relapsed/refractory multiple myeloma and relapsed/refractory non-Hodgkin lymphoma. The tr…